このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Mindful Awareness Program for the Prevention of Dementia: A Randomized Controlled Trial (MAPRCT)

2015年8月16日 更新者:Rathi Mahendran、National University, Singapore

The objective of this study is to determine whether regular Mindful Awareness Program (MAP) may reverse cognitive impairment and/or prevent further cognitive decline among older adults. 60 elderly with mild cognitive impairment (MCI) were randomized to participate in either the MAP or the Health Education Program (HEP). Sessions will be conducted weekly for 12 weeks, and monthly for 6 months. Participants would be assessed at 3 time-points: at the start, at 3-months and at 9-months.

It was hypothesized that as compared to HEP participants, MAP participants will (1) have improved functional connectivity, (2) have a decreased risk in cognitive decline and (3) report higher psychological well-being.

調査の概要

詳細な説明

Participants Study participants are community-dwelling elderly.

Assessments Demographic data will be collected at the start. Psychological tests for depression and anxiety and neuropsychological tests of cognitive functioning will be done at the start, at 3-months and at 9-months, the end of the study. A urine sample will be collected at the start and at the end of the study; blood, fecal and saliva samples will be collected at all three time points. Participants will also undergo a brain neuro-imaging scan at the start of the study and at the 3-months interval.

Intervention Sessions This is an intervention study with a control group design. The strength of this design is its experimental nature with randomization. The control group is the health education program participants.

In the Mindful Awareness Program, all 30 participants will be seen in a group format once a week for 40 minutes for 12 weeks, followed by once a month for 40 minutes for 6 months. The intervention is modelled on similar groups teaching mindfulness meditation to the elderly. The sessions will be led by an experienced instructor who has conducted pilot studies on the use of mindful awareness practice techniques with the elderly.

Participants shall be required to practice these techniques at home daily and will be asked to keep a log of their practice.

For the Health Education Program, all 30 participants will be seen in a group format once a week for 40 minutes for 12 weeks, followed by once a month for 40 minutes for 6 months. Each weekly session will cover a healthy living topic related to maintaining and improving cognitive function. The monthly sessions will review the topics covered with a discussion of how participants have implemented the imparted knowledge to their daily lives. The sessions will be led by an experienced instructor who has conducted similar teaching sessions to the elderly.

Participants will be provided with hand-outs at each session, and there will be discussions to encourage them to practice what is being taught in their daily lives.

研究の種類

介入

入学 (実際)

55

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Singapore、シンガポール、648886
        • Training and Research Academy

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

60年~85年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  1. an elderly person between the age of 60 and 85 living in the community and fulfill the operational criteria/definition of MCI:

    1. At least one age-education adjusted neuropsychological test Z score < -1.5
    2. Do not meet DSM-IV criteria for dementia syndrome
    3. Memory / Cognitive complaint, preferably corroborated by a reliable informant
    4. Intact Activities of Daily Living.
  2. function independently
  3. do not suffer from dementia,
  4. able to travel on their own to the data collection site and participate in the MAP or HEP

Exclusion Criteria:

  1. Those who do not meet the above inclusion criteria (ie. Do not have a MCI diagnosis),
  2. Those with Dementia or Normal Ageing
  3. Have a neurological condition (e.g., epilepsy, Parkinson's Disease),
  4. Have a major psychiatric condition (e.g., major depressive disorder)
  5. Suffer from a terminal illness (e.g., cancer).
  6. Have significant visual or hearing impairment, or
  7. Marked upper and lower limb motor difficulties, which may affect their ability to participate in the study.
  8. Are in another interventional study at the same time

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Mindful Awareness Program
18 sessions of mindful awareness program teaching the elderly mindful awareness practice techniques
For Mindful Awareness Program, 40-minutes weekly sessions for 12 weeks, followed by 40-minutes monthly for 6 months. The mindful awareness practice techniques to be taught to the elderly include: (1) mindfulness of the senses practice; (2) the body scan practice; (3) walking meditation practice; (4) 'movement nature meant' practice; and (5) visuo-motor limb tasks
他の名前:
  • 地図
アクティブコンパレータ:Health Education Program
18 sessions of health education program focusing on healthy living topics

For the Health Education Program, weekly sessions of 40 minutes for 12 weeks, followed by monthly sessions of 40 minutes for 6 months.

Week 1: Diabetes Mellitus Week 2: Hypertension Week 3: Home Safety Week 4: Medications Week 5: Diet Week 6: Depression Week 7: Dementia Week 8: Anxiety Week 9: Sleep Week 10: Exercise Week 11: Coping with bereavement Week 12: Social support

他の名前:
  • HEP

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change from baseline Mini-Mental State Examination (MMSE) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Mini-Mental State Examination (MMSE) is a brief 30-point questionnaire administered by health care professionals to screen for cognitive impairment. The score ranges from 0 to 30; the higher the score, the less impaired is the participant's cognitive function.
baseline, 3-months, 9-months
Change from baseline Clinical Dementia Rating (CDR ) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Clinical Dementia Rating (CDR ) is a 5-point scale used to characterize six domains of cognitive and functional performance applicable to Alzheimer disease and related dementias: Memory, Orientation, Judgment & Problem Solving, Community Affairs, Home & Hobbies, and Personal Care.
baseline, 3-months, 9-months
Change from baseline Rey Auditory Verbal Learning Test (RAVLT) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Rey Auditory Verbal Learning Test (RAVLT) evaluates declarative verbal learning and memory.
baseline, 3-months, 9-months
Change from baseline Digit Span Task at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Digit Span Task, which consists of a Digit Span Forward (DSF) and a Digit Span Backward (DSB) task is used to assess attention and verbal working memory.
baseline, 3-months, 9-months
Change from baseline Colour Trails Tests (CTT) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Colour Trails Tests (CTT) 1 and 2 assesses sustained attention and sequencing.
baseline, 3-months, 9-months
Change from baseline Block Design at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Block Design is a subtest that is administered as part of several of the Wechsler Intelligence tests, and it primarily measures visual-spatial and organizational processing abilities, as well as non-verbal problem-solving skills.
baseline, 3-months, 9-months
Change from baseline Semantic Verbal Fluency (Animals) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Semantic Verbal Fluency (Animals) taps lexical knowledge and semantic memory organization.
baseline, 3-months, 9-months
Change from baseline fMRI scan at 3 months
時間枠:baseline, 3-months
Functional Magnetic Resonance Imaging (fMRI) will be employed to examine changes in functional connectivity. Images will be acquired on a 3T Siemens scanner using a standard Siemens whole head coil. All subjects will undergo the task-free fMRI scan after being instructed only to remain awake with their eyes closed. White Matter Diffiusion Tractography Imaging (DTI) will be utilized to identify anatomical connections between functionally correlated regions . The MRI Brain Scan is non-invasive and does not involve the use of Contrast; duration of each scan is approximately one hour.
baseline, 3-months
Change from baseline Biomarkers: blood sample at 3 months and 9 months
時間枠:baseline, 3-months, 9-months

5 ml of blood will be collected using plasma tubes with indomethacin (15uM final conc) and BHT (20ul of 2mM) will be added prior to freezing (-80 Degree Celsius) to preserve the sample and prevent artifacts (at baseline, 3 months, 9 months).

3 ml of blood will be collected using tubes with no coagulant (at baseline, 3 months and 9 months).

5 ml of blood will be collected using Tempus Blood RNA tubes and will be stored in a refrigerator at approximately 4 Degree Celsius (at baseline and 9 months).

Blood sample would be analysed for cytokine levels; chromosomal studies and terminal telomere restriction fragment length.

baseline, 3-months, 9-months
Change from baseline Biomarkers: urine sample at 9 months
時間枠:baseline, 9-months
15 ml sample of urine will be collected and frozen as quickly as possible. Urine sample would be analysed for oxidative biomarkers.
baseline, 9-months
Change from baseline Biomarker - fecal sample at 3 months and 9 months
時間枠:baseline,3 months, 9 months
A fecal sample will also be collected in a tube with RNALater and microbeads. These can be kept at 40C till processing. Fecal sample would be analysed for bacteria.
baseline,3 months, 9 months
Change from baseline Biomarker - saliva sample at 3 months and 9 months
時間枠:baseline,3 months, 9 months
Saliva will be collected in a test-tube by having participants continuously spit into a 50ml centrifuge tube for 5 minutes. Saliva sample would be analysed for salivary cortisol analysis, DNA extraction and sequencing for stress biomarkers (cytokines).
baseline,3 months, 9 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Change from baseline Basic Health Screen at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
the Blood pressure, Pulse rate, Height and Weight will be measured.
baseline, 3-months, 9-months
Change from baseline Activities of daily Living (ADL) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Activities of daily Living (ADL) is a questionnaire to screen for functional assessment.
baseline, 3-months, 9-months
Change from baseline Instrumental Activities of Daily Living (IADL) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Instrumental Activities of Daily Living (IADL) is a questionnaire to screen for functional assessment.
baseline, 3-months, 9-months
Change from baseline Geriatric Depression Scale (GDS) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Psychological well-being will be assessed using the Geriatric Depression Scale. Subjects with high scores will not be enrolled into the study and will be informed of the scores and advised to see a doctor at a polyclinic or their family physician with a referral letter prepared for this purpose.
baseline, 3-months, 9-months
Change from baseline Geriatric Anxiety Inventory (GAI) at 3 months and 9 months
時間枠:baseline, 3-months, 9-months
Psychological well-being will be assessed using the Geriatric Anxiety Inventory (GAI). Subjects with high scores will not be enrolled into the study and will be informed of the scores and advised to see a doctor at a polyclinic or their family physician with a referral letter prepared for this purpose.
baseline, 3-months, 9-months

その他の成果指標

結果測定
時間枠
Demographic questionnaire
時間枠:Baseline
Baseline

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Rathi Mahendran, Ph.D、National University, Singapore

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2014年9月1日

一次修了 (実際)

2015年6月1日

研究の完了 (実際)

2015年6月1日

試験登録日

最初に提出

2014年11月3日

QC基準を満たした最初の提出物

2014年11月5日

最初の投稿 (見積もり)

2014年11月10日

学習記録の更新

投稿された最後の更新 (見積もり)

2015年8月18日

QC基準を満たした最後の更新が送信されました

2015年8月16日

最終確認日

2015年8月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する